Patricia G Smith, ARNP, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1750 Indianola Cemetery Rd, Indianola, OK 74442 Phone: 918-302-7502 |
News Archive
Women who take a vitamin B9 supplement (folic acid) during the beginning weeks of their pregnancy can cut the risk of having a child with autism in half. But the supplement has no effect if it is started more than 8 weeks into the pregnancy.
In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin - the active compound in hallucinogenic "magic mushrooms."
University of Utah metallurgists used an old microwave oven to produce a nanocrystal semiconductor rapidly using cheap, abundant and less toxic metals than other semiconductors. They hope it will be used for more efficient photovoltaic solar cells and LED lights, biological sensors and systems to convert waste heat to electricity.
Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.
Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their respective subsidiaries reported today a combined total operating revenue of $11.0 billion for the quarter ended June 30, 2010, compared to $10.5 billion in the same period in 2009. Operating income was $313 million in the second quarter of 2010, compared to $411 million in the same quarter last year.
› Verified 8 days ago